News

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...